Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Selective antagonists of benzodiazepines
19811.1k citationsH. Möhler, L. Pieri et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of W. Haefely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Haefely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Haefely more than expected).
This network shows the impact of papers produced by W. Haefely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Haefely. The network helps show where W. Haefely may publish in the future.
Co-authorship network of co-authors of W. Haefely
This figure shows the co-authorship network connecting the top 25 collaborators of W. Haefely.
A scholar is included among the top collaborators of W. Haefely based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W. Haefely. W. Haefely is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Haefely, W.. (1988). Partial agonists of the benzodiazepine receptor: from animal data to results in patients.. PubMed. 45. 275–92.29 indexed citations
8.
Haefely, W.. (1988). The preclinical pharmacology of flumazenil.. PubMed. 2. 25–36.45 indexed citations
Pieri, L., R. Schaffner, R. Scherschlicht, et al.. (1981). Pharmacology of midazolam.. PubMed. 31(12a). 2180–201.127 indexed citations
12.
Haefely, W.. (1979). Involvement of GABA in the actions of neuropsychotropic drugs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(1-4). 53–66.7 indexed citations
Thoenen, H., W. Haefely, G. Haeusler, & A. Huerlimann. (1968). Formation of a "false" adrenergic transmitter in cats pretreated with 4-methyoxy-3,5-dihydroxyphenylalanine and its effects on postganglionic sympathetic transmission.. PubMed. 162(1). 70–9.2 indexed citations
Thoenen, H., W. Haefely, Gey Kf, & A. Hürlimann. (1966). [The replacement of noradrenaline by dopamine as a postganglionic sympathetic transmitter in the inhibition of dopamine beta-hydroxylase by disulfiram].. PubMed. 68. C118–9.2 indexed citations
Haefely, W., A. Huerlimann, & H. Thoenen. (1964). [STRUCTURE-ACTIVITY RELATIONS IN A SERIES OF PHENYLETHYLAMINES AFTER FUNCTIONAL ISOLATION OF THEIR EFFECT ON ADRENERGIC RECEPTORS].. PubMed. 64. C125–7.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.